Circadian regulation of cardiovascular function: a role for vasoactive intestinal peptide

被引:27
|
作者
Schroeder, Analyne
Loh, Dawn H.
Jordan, Maria C. [2 ]
Roos, Kenneth P. [2 ]
Colwell, Christopher S. [1 ]
机构
[1] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst Neurosci, Los Angeles, CA 90024 USA
[2] Univ Calif Los Angeles, Physiol & Cardiovasc Res Lab, Los Angeles, CA 90024 USA
关键词
heart rate; body temperature; ISCHEMIC-HEART-DISEASE; LONG-QT SYNDROME; SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; VPAC(2) RECEPTOR; DEFICIENT MICE; MESSENGER-RNA; CLOCK NEURONS; SHIFT WORK; RHYTHM;
D O I
10.1152/ajpheart.00190.2010
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Schroeder A, Loh DH, Jordan MC, Roos KP, Colwell CS. Circadian regulation of cardiovascular function: a role for vasoactive intestinal peptide. Am J Physiol Heart Circ Physiol 300: H241-H250, 2011. First published October 15, 2010; doi: 10.1152/ajpheart.00190.2010.-The circadian system, driven by the suprachiasmatic nucleus (SCN), regulates properties of cardiovascular function. The dysfunction of this timing system can result in cardiac pathology. The neuropeptide vasoactive intestinal peptide (VIP) is crucial for circadian rhythms in a number of biological processes including SCN electrical activity and wheel running behavior. Anatomic evidence indicates that SCN neurons expressing VIP are well positioned to drive circadian regulation of cardiac function through interactions with the autonomic centers. In this study, we tested the hypothesis that loss of VIP would result in circadian deficits in heart rate (HR) and clock gene expression in cardiac tissue. We implanted radiotelemetry devices into VIP-deficient mice and wild-type (WT) controls and continuously recorded HR, body temperature, and cage activity in freely moving mice. Under light-dark conditions, VIP-deficient mice displayed weak rhythms in HR, body temperature, and cage activity, with onsets that were advanced in phase compared with WT mice. Similarly, clock gene expression in cardiac tissue was rhythmic but phase advanced in mutant mice. In constant darkness, the normal circadian rhythms in HR were lost in VIP-deficient mice; however, most mutant mice continued to exhibit circadian rhythms of body temperature with shortened free-running period. The loss of VIP altered, but did not abolish, autonomic regulation of HR. Analysis of the echocardiograms did not find any evidence for a loss of cardiac function in VIP-deficient mice, and the size of the hearts did not differ between genotypes. These results demonstrate that VIP is an important regulator of physiological circadian rhythmicity in the heart.
引用
收藏
页码:H241 / H250
页数:10
相关论文
共 50 条
  • [21] Vasoactive intestinal peptide is a local regulator of adrenocortical function
    Hinson, JP
    Ho, MM
    Vinson, GP
    Kapas, S
    ENDOCRINE RESEARCH, 1996, 22 (04) : 831 - 838
  • [22] VASOACTIVE INTESTINAL PEPTIDE AND ANTERIOR-PITUITARY FUNCTION
    PRYSORJONES, RA
    JENKINS, JS
    CLINICAL ENDOCRINOLOGY, 1988, 29 (06) : 677 - 688
  • [24] EFFECTS OF VASOACTIVE INTESTINAL PEPTIDE ON DEVELOPING CANINE CARDIOVASCULAR HEMODYNAMICS
    MAS, MS
    ADAMS, DJ
    ESCOBAR, AB
    GELBAND, H
    PEDIATRIC RESEARCH, 1989, 25 (04) : A242 - A242
  • [25] Regulation of vasoactive intestinal polypeptide release in the suprachiasmatic nucleus circadian clock
    Francl, Jessica M.
    Kaur, Gagandeep
    Glass, John David
    NEUROREPORT, 2010, 21 (16) : 1055 - 1059
  • [26] A Role for Vasoactive Intestinal Peptide Interneurons in Neurodevelopmental Disorders
    Goff, Kevin M.
    Goldberg, Ethan M.
    DEVELOPMENTAL NEUROSCIENCE, 2021, 43 (3-4) : 168 - 180
  • [27] The Role of Vasoactive Intestinal Peptide (VIP) in Megakaryocyte Proliferation
    Nam, Chaneun
    Case, Adam J.
    Hostager, Bruce S.
    O'Dorisio, M. Sue
    JOURNAL OF MOLECULAR NEUROSCIENCE, 2009, 37 (02) : 160 - 167
  • [28] The Role of Vasoactive Intestinal Peptide (VIP) in Megakaryocyte Proliferation
    Chaneun Nam
    Adam J. Case
    Bruce S. Hostager
    M. Sue O’Dorisio
    Journal of Molecular Neuroscience, 2009, 37 : 160 - 167
  • [29] Potential Therapeutic Role of Vasoactive Intestinal Peptide in Diabetes
    Sanlioglu, Ahter Dilsad
    Karacay, Bahri
    Balci, Mustafa Kemal
    Griffith, Thomas S.
    Sanlioglu, Salih
    HUMAN GENE THERAPY, 2012, 23 (10) : A150 - A150
  • [30] THE ROLE OF VASOACTIVE INTESTINAL POLYPEPTIDE IN THE CARDIOVASCULAR-SYSTEM
    UNVERFERTH, DV
    MILLER, MM
    HAMLIN, RL
    LEIER, CV
    ODORISIO, TM
    CLINICAL RESEARCH, 1982, 30 (02): : A227 - A227